121批归脾丸的质量考察及标准商榷  

Discuss on The Investigate of Quality and Quality Standard of for 121 batch Guipi Pills

作　　者：贾荷丽[1] 姬诚[1] 黄海欣 

机构地区：[1]河南省南阳医学高等专科学校,南阳473061 [2]河南省南阳市食品药品检验所,南阳473000

出　　处：《光明中医》2013年第10期2052-2053,共2页GUANGMING JOURNAL OF CHINESE MEDICINE

摘　　要：目的归脾丸的质量考察。方法对121批归脾丸作了性状,薄层色谱鉴别,检查和含量测定等方面的检验。结果121批归脾丸中有11批不合格,不合格率为9.1%。结论要加强归脾丸的质量管理,保证临床用药安全有效。Objective To investigate the quality and quality standard of Guipi pills. Methods 121 batches of Guipi pill were determined by characters, TLC, check and content determination. Results 11 batch didn＇t pass so the unqualified rate was 9. 1%. Conclusion We should strengthen the quality of spleen pill to management, guarantee the safe and effective of clinical medication.

关 键 词：归脾丸 质量考察 薄层色谱 含量测定 

分 类 号：R286[医药卫生—中药学]